Position Purpose Maximize urothelial cancer business managing in-line prostate cancer product and developing bladder cancer portfolio(New products) Develop synergistic strategy of PC and BC to deliver holistic approach Deliver the agreed forecast budget and business plan for BC
Johnson & Johnson is seeking an experienced candidate to lead external partnership and M&A initiatives for its MedTech business in Japan, supporting the companys innovation and growth agenda. The Director of New Business Development, Japan will report directly
After 10 years of continuous growth, Janssen Japan (JPKK) business is faced with two years of solid growth in 2024 and 2025. This is an important period to ensure successful delivery of our performance goals. As importantly,
Reporting to the Business Insights & Analytics (BI&A) Center of Excellence (CoE), APAC, you will make a significant impact in Johnson and Johnson Innovative medicines Japan to drive market leading, insight led competitiveness. You will lead best
•Position Purpose •Develop and deliver strategies to give our company customer facing teams a competitive edge with personalized engagement as well as data-driven insights using advanced commercial processes, systems and tools •Key Responsibility Areas •Establish the
Johnson & Johnson is recruiting for a TS ASPAC SD/Logistics J&J internal consultant leader in Japan to be the technical lead for the upcoming SAP S/4 Hana Transformation initiative from 2023. This Supply Chain Digitalization program
Position Purpose Develop and implement the business strategy for the HEM product portfolio, with both short-term and long-term business objectives. Oversee and lead all marketing and sales plans to achieve the business objectives within policies and guidelines as well
Position Purpose Develop and implement a business strategy for the assigned Business Unit with both short term and long-term business objectives Oversee and lead all marketing and sales plans to achieve the business objectives within policies and guidelines as well
After 10 years of continuous growth, Janssen Japan (JPKK) business is faced with two years of solid growth in 2024 and 2025. This is an important period to ensure successful delivery of our performance goals. As importantly,
